Posts

Showing posts from January, 2026

Long COVID vs ME/CFS: Symptoms, Mechanisms, and Post-Viral Insights (2026)

Image
Long COVID vs ME/CFS: Understanding Post-Viral Syndromes Long COVID (post-acute sequelae of SARS-CoV-2 infection, PASC) and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) are two post-viral syndromes that share overlapping symptoms such as fatigue, brain fog, and post-exertional malaise. However, recent studies highlight unique mechanistic and clinical differences, particularly in inflammation, endothelial injury, and energy metabolism. This article provides an evidence-based comparison, with links to related topics on spike protein persistence, endothelial dysfunction, mitochondrial dysfunction & NAD⁺, and nutraceutical interventions. Epidemiology: Who Gets Long COVID vs ME/CFS? Key Points: Long COVID affects ~10–30% of COVID survivors (WHO, 2023) ME/CFS affects ~0.2–0.5% of the population (Jason et al., 2021) Long COVID can affect all age groups, peak 40–60; ME/CFS peaks 30–50 Both show female predominance; stronger in ME/CFS Related:   Long COVID overview Clinic...

Vitamin D May Improve Post-COVID-19 Vaccine Chronic Fatigue Syndrome: Study (2025)

Image
The study titled, Efficacy of vitamin D replacement therapy on 28 cases of myalgic encephalomyelitis/chronic fatigue syndrome after COVID-19 vaccination , was published in Nutrition (2025): Background Prolonged symptoms have been reported following both COVID-19 infection and vaccination, with some cases leading to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Of 80 patients presenting to our hospital with postvaccination syndrome, 28 met the diagnostic criteria for ME/CFS. We conducted a retrospective study on these 28 patients. Methods We measured serum 25-hydroxyvitamin D levels in 28 patients who developed ME/CFS after COVID-19 vaccination between August 2022 and February 2024. Vitamin D replacement therapy included dietary counseling, sun exposure recommendations, and oral vitamin D supplementation. We evaluated changes in blood vitamin D levels and symptom improvement. Results At initial visit, 27 of 28 patients diagnosed with ME/CFS had insufficient or deficient...

The Role of Metabolic Health in Better COVID-19 Outcomes

Image
Return guest Dr. Paul Saladino is a board-certified psychiatrist and also board certified in nutrition. He wrote "The Carnivore Code," which just came out in an updated second edition. In this interview, he discusses the impact metabolic health has on COVID-19 outcomes. He's done a magnificent job explaining the science that supports the natural lifestyle strategies that optimize our immune systems to defeat not only COVID-19, but also most other infectious agents. "The psychiatry was a jump-off point for thinking about how immune function and metabolic health affects mental health," he says. "I quickly realized that everything in the body was connected and I couldn't just focus on the brain without focusing on the rest of the body, and that has led us to where we are today. I think that as we are faced with coronavirus, it's a reminder of the metabolic health and how critical that is. I think so much of the...

Nutraceuticals & Long COVID: What Clinical Science Supports (and What Doesn’t)

Image
Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is characterized by persistent symptoms such as fatigue, dyspnea, cognitive impairment, and dysautonomia. Interest in nutraceuticals —dietary supplements, herbal extracts, and vitamins—has grown as potential adjuncts to symptom management. This review evaluates current clinical and preclinical evidence for commonly discussed nutraceuticals, including curcumin, N-acetylcysteine (NAC), omega-3 fatty acids, nattokinase, bromelain and probiotics, and contrasts them with established evidence-based clinical management. While some nutraceuticals demonstrate mechanistic plausibility for anti-inflammatory or antioxidant effects, high-quality clinical trial evidence supporting their efficacy in Long COVID is largely absent. Clinicians and patients should consider nutraceuticals as adjunctive therapy under supervision , prioritizing guideline-recommended interventions such as multidisciplinary care, rehabilitation, and s...

What the Evidence Says About Spike Protein in Long COVID & Post‑Vaccination (2026)

Image
Abstract Persistent symptoms following SARS‑CoV‑2 infection, collectively termed Long COVID or post‑acute sequelae of COVID‑19 (PASC), remain a significant clinical challenge. One proposed biological mechanism involves prolonged presence of SARS‑CoV‑2 spike protein or viral RNA fragments post‑infection. Additional questions concern spike protein dynamics after COVID‑19 vaccination. This review synthesizes current peer‑reviewed evidence on spike protein detection after natural infection and vaccination, clarifying clinical context, limitations, and implications. Data indicate that SARS‑CoV‑2 spike protein and/or fragments can be detected in circulation or tissues up to a year or longer post‑infection, especially in PASC cohorts, whereas vaccine‑derived spike is typically transient and associated with rapid immune clearance. Mechanistic and clinical significance remains an area of ongoing research. Keywords: SARS‑CoV‑2, spike protein, long COVID, PASC, post‑vaccination, antigen persiste...

Labels

Show more

Archive

Show more